STAT News

STAT News. It is a digital media company focusing on health care, medicine, and life sciences journalism, launched in November 2015. Owned by John Henry, who also owns The Boston Globe and the Boston Red Sox, it operates as an independent entity with a mission to deliver fast, deep, and tough-minded coverage of the biotechnology and pharmaceutical industry. The publication is headquartered in Boston, a major hub for the life sciences industry, and maintains bureaus in Washington, D.C., New York City, and San Francisco.

History and founding

STAT News was launched on November 4, 2015, by John Henry, the principal owner of The Boston Globe and the Fenway Sports Group. The founding was a strategic move to create a dedicated, high-quality news outlet for the rapidly expanding biotechnology and pharmaceutical industry sectors, capitalizing on the journalistic talent and infrastructure of The Boston Globe. The site's first executive editor was Rick Berke, a veteran of The New York Times and Politico, who helped assemble an initial team of reporters from prestigious outlets like The Washington Post, Bloomberg News, and The Wall Street Journal. Its launch was seen as part of a broader trend of niche, subscription-based digital journalism ventures emerging in the 2010s, distinct from traditional newspaper models.

Content and coverage

The publication's core coverage areas include biotechnology, pharmaceuticals, health policy, medical research, and the Food and Drug Administration. It produces a mix of daily news reporting, in-depth investigative pieces, and feature stories, with a notable emphasis on exclusive reporting and data journalism. Key verticals include "STAT+", a premium subscription service offering exclusive analysis and reports, and "First Opinion", a platform for commentary from physicians, researchers, and health policy experts. Its reporting has broken major stories on drug pricing, clinical trial outcomes, gene editing controversies involving technologies like CRISPR, and the inner workings of companies such as Theranos and Valeant Pharmaceuticals.

Business model and operations

STAT News operates primarily on a freemium model, where basic daily news is free but in-depth analysis, special reports, and certain data tools are behind a paywall under its "STAT+" subscription tier. This model is supported by corporate sponsorships, native advertising, and live event hosting, such as its annual "STAT Summit". While initially incubated within the infrastructure of The Boston Globe, it functions as an independent LLC. The newsroom is led by Executive Editor Rick Berke and employs journalists across its bureaus in Boston, Washington, D.C., and San Francisco, focusing on areas critical to the life sciences industry and federal government health agencies.

Impact and recognition

The outlet has gained significant influence within the health care and science journalism communities, known for its aggressive reporting on the pharmaceutical industry and public health crises. Its coverage of the COVID-19 pandemic was widely cited, including reporting on vaccine development by Pfizer and Moderna, treatments like remdesivir, and government responses from the Centers for Disease Control and Prevention and the National Institutes of Health. STAT News has been a finalist for and won several awards, including the National Magazine Award for Reporting and the Kaiser Family Foundation Award for Excellence in Health Reporting. Its journalists have been recognized by the American Association for the Advancement of Science and the Society of Professional Journalists.

Criticism and controversies

As a publication deeply embedded in covering the profitable biotechnology sector, it has faced scrutiny over potential conflicts of interest, given its reliance on subscription revenue from industry professionals and sponsorship from health care companies. Some critics have questioned the tone of its "STAT+" content, suggesting a proximity to industry perspectives. It has also been involved in legal tensions, notably a 2016 dispute with the Department of Health and Human Services over access to Medicare data. Furthermore, its aggressive competitive stance and paywall strategy have sparked debates about accessibility of vital health policy information.

Category:American news websites Category:Healthcare journalism Category:Companies based in Boston Category:Digital media in the United States